The results of Russian multicenter open-label observational study of the efficacy and safety of Melaxen (melatonin) for the treatment of disordered sleep in patients with chronic cerebral ischemia

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova

Volumn 112, Issue 9, 2012, Pages 26-31

  Poluektov, M G ^a   Levin, Ya I ^a   Boiko, A N ^a   Skoromets, A A ^a   Belskaya, G N ^a   Gustov, A V ^a   Doronin, B M ^a   Poverennova, I E ^a   Spirin, N N ^a   Yakupov, E Z ^a  

^a I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Chronic cerebral ischemia; Insomnia; Melaxen (melatonin)

Indexed keywords

MELATONIN; MELAXEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN ISCHEMIA; EPWORTH SLEEPINESS SCALE; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OPEN STUDY; PSYCHOMETRY; SLEEP DISORDER; MIDDLE AGED; MULTICENTER STUDY;

BRAIN ISCHEMIA; FEMALE; HUMANS; MALE; MELATONIN; MIDDLE AGED; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 84877027486     PISSN: 19977298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Achermann P., Borbély A.A. Combining different models of sleep regulation. J Sleep Res 1992; 1: 2: 144-147.
2. American Academy of Sleep Medicine. International classification of sleep disorders, 2nd ed.: Diagnostic and coding manual. Westchester, Ill.: American Academy of Sleep Medicine 2005.
3. Bassetti C. Sleep and stroke. In: Principles and practice of sleep medicine [edited by]. M.H. Kryger, T. Roth, W.C. Dement. 5th ed. St. Louis, Missouri: Elsevier Saunders 2011; 993-1015.
4. Buysse D.J., Hall M.L., Strollo P.J., Kamarck T.W., Owens J., Lee L., Reis S.E., Matthews K.A. Relationships between the Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS), and clinical/polysomnographic measures in a community sample. J Clin Sleep Med 2008; 4: 6: 563-571.
5. Cardinali D.P., Srinivasan V., Brzezinski A., Brown G.M. Melatonin and its analogs in insomnia and depression. J Pineal Res 2012; 52: 4: 365-375.
6. Hróbjartsson A., Gøtzsche P.C. Placebo interventions for all clinical conditions. Cochrane Database Syst Rev 2010; 1: CD003974.
7. Johns M.W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14: 6: 540-545.
8. Wyatt J.K., Dijk D.J., Ritz-de Cecco A., Ronda J.M., Czeisler C.A. Sleep-facilitating effect of exogenous melatonin in healthy young men and women is circadian-phase dependent. Sleep 2006; 29: 5: 609-618.
9. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 6: 361-370.